BioFinland 05: Focus on Genomic Drug Discovery
BioFinland 05 is a two-day biotechnology congress that will bring together scientists, entrepreneurs and investors in the emerging biotech sector. The congress with its theme Genomic Drug Discovery will approach the entire drug discovery chain from bench to bedside. Identification of targets, validation, and clinical trials are dramatically changing as a consequence of powerful genomics tools being applied in all these areas.
The BioFinland Congress will open on Tuesday April 26, 2005 with a plenary session followed by two parallel sessions in the afternoon. Wednesday April 27, 2005 will follow the same pattern.
The Congress Highlights
- Latest results from both big pharma companies and fresh start-ups
- Emerging technologies and applications from the academia
- Excellent networking possibilities
“Drug discovery and improvements in drug choices and diagnostics are being revolutionized by genomics and the possibilities this is opening up for the biotechnology sector are staggering.”
Professor Tomi Mäkelä, Chair of the Programme Committee, University of Helsinki
“The success of combining a truly cutting edge scientific program with a biotech exhibition and investor forum was demonstrated with our previous congress in 2003, and there is no doubt that the excellent program of BioFinland 05 will prove attractive to a wide audience from the academia, investors, and the biotech industry.”
Professor Leena Peltonen-Palotie, University of Helsinki and National Public Health Institute (Finland)